辉瑞 PFE 深 沪
等待开盘 10-08 09:30:00 美东时间
26.27
-0.160
-0.61%
华盛通- 最 高26.58
- 今 开26.42
- 成交量 4760.25万股
- 最 低 26.05
- 昨 收 26.43
- 总市值 1493.71亿
- 52周最高 27.69
- 市盈率 静 18.67
- 换手率 0.84%
- 52周最低 20.055
- 委 比 -1.17%
- 总股本 56.86亿
- 历史最高 55.50
- 量 比 0.46
- 振 幅 2.01%
- 历史最低 -2.1873
- 每 手 1
- 风险率 1.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Eli Lilly reports positive results from ulcerative colitis trial
Eli Lilly (NYSE:LLY) announced positive results from a late-stage trial of Omvoh (mirikizumab-mrkz) for patients suffering from moderately to severely active ulcerative colitis. The study demonstrated...
10-07 21:57
诺奖点燃多个千亿市场，辉瑞、阿斯利康都在下注
本文来自格隆汇专栏：虎嗅，作者：陈广晶 诺奖又上演了“意料之外，情理之中”的剧情。 10月6日，2025年诺贝尔生理学或医学奖揭晓，美国科学家玛丽·E·布伦科...
10-07 23:22
美股异动|辉瑞股价跌3.43%背后政策协议引发市场疑虑
（来源：美股情报站） 近期辉瑞股价的下跌引发了市场的广泛关注。10月6日，辉瑞的股价下跌了3.43%，这在一定程度上反映了市场对其未来发展的疑虑。然而在背后...
10-07 06:32
AstraZeneca, Daiichi Sankyo succeed in late-stage breast cancer study
AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo said that its late-stage study of Datroway (datopotamab deruxtecan), being evaluated as a first-line treatment for patients with triple-negative breast canc...
10-07 01:47
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
10-07 01:35
Will valuations see a floor? – Morgan Stanley’s Mike Wilson
If nominal GDP and earnings growth accelerate due to higher inflation, stocks’ valuation may see a support ahead, according to Michael J. Wilson, chief U.S. equity strategist and chief investment offi...
10-07 00:51
CDC adopts individual-based decision-making for COVID-19 shots
The CDC has followed the recommendation of its vaccine advisory panel made in September that COVID-19 booster shots be based on "individual-based decision-making." The updated immunization schedule is...
10-06 23:47
Ryoncil® Revenues Increase 66% in Second Quarter Post Launch
Mesoblast Limited reported a 66% increase in Q3 2025 revenue for Ryoncil® to $21.9 million, driven by strong adoption and reimbursements. Ryoncil® is the first FDA-approved mesenchymal stromal cell (MSC) therapy for children under 12 with steroid-refractory acute graft-versus-host disease. The company attributes growth to the permanent J-Code assignment by CMS. Mesoblast focuses on allogeneic cellular medicines for inflammatory diseases with a ro...
10-06 23:24
Amgen to offer Repatha at 60% discount to U.S. consumers
Amgen (NASDAQ:AMGN) said on Monday that it has launched its cholesterol medication, Repatha, directly to consumers in the U.S. at a reduced cash price. This move comes as part of a broader response fr...
10-06 23:12
公司简介
公司名称
|
辉瑞
|
行业分类
|
制药
|
业务描述
|
在辉瑞，我们致力于运用科学以及我们的全球资源来改善每个生命阶段的健康状况。在药品的探索、开发和生产过程中，我们多样化的全球保健产品包括生物药品、小分子药品和疫苗，以及许多世界驰名的健康药物。每天，世界各地的辉瑞员工致力于推进健康，以及能够应对我们这个时代最为棘手的疾病的预防和治疗方案。辉瑞还与世界各地的医疗卫生专业人士、政府和社区合作，支持世界各地的人们能够获得更为可靠和可承付的医疗卫生服务。这与辉瑞作为一家世界领先的生物制药公司的责任是一致的。160多年来，辉瑞一直努力为人们提供更好、更优质的服务。
2016年收入528亿美元，全球63个生产基地，业务遍布全球约175个国家和地区，有9种产品的销售额超过10亿美元，2016年新增140多个研发合作机构，全球96,500余名员工。
|
Eli Lilly reports positive results from ulcerative colitis trial
Eli Lilly (NYSE:LLY) announced positive results from a late-stage trial of Omvoh (mirikizumab-mrkz) for patients suffering from moderately to severely active ulcerative colitis. The study demonstrated...
10-07 21:57
诺奖点燃多个千亿市场，辉瑞、阿斯利康都在下注
本文来自格隆汇专栏：虎嗅，作者：陈广晶 诺奖又上演了“意料之外，情理之中”的剧情。 10月6日，2025年诺贝尔生理学或医学奖揭晓，美国科学家玛丽·E·布伦科...
10-07 23:22
美股异动|辉瑞股价跌3.43%背后政策协议引发市场疑虑
（来源：美股情报站） 近期辉瑞股价的下跌引发了市场的广泛关注。10月6日，辉瑞的股价下跌了3.43%，这在一定程度上反映了市场对其未来发展的疑虑。然而在背后...
10-07 06:32
AstraZeneca, Daiichi Sankyo succeed in late-stage breast cancer study
AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo said that its late-stage study of Datroway (datopotamab deruxtecan), being evaluated as a first-line treatment for patients with triple-negative breast canc...
10-07 01:47
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
10-07 01:35
Will valuations see a floor? – Morgan Stanley’s Mike Wilson
If nominal GDP and earnings growth accelerate due to higher inflation, stocks’ valuation may see a support ahead, according to Michael J. Wilson, chief U.S. equity strategist and chief investment offi...
10-07 00:51
CDC adopts individual-based decision-making for COVID-19 shots
The CDC has followed the recommendation of its vaccine advisory panel made in September that COVID-19 booster shots be based on "individual-based decision-making." The updated immunization schedule is...
10-06 23:47
Ryoncil® Revenues Increase 66% in Second Quarter Post Launch
Mesoblast Limited reported a 66% increase in Q3 2025 revenue for Ryoncil® to $21.9 million, driven by strong adoption and reimbursements. Ryoncil® is the first FDA-approved mesenchymal stromal cell (MSC) therapy for children under 12 with steroid-refractory acute graft-versus-host disease. The company attributes growth to the permanent J-Code assignment by CMS. Mesoblast focuses on allogeneic cellular medicines for inflammatory diseases with a ro...
10-06 23:24
Amgen to offer Repatha at 60% discount to U.S. consumers
Amgen (NASDAQ:AMGN) said on Monday that it has launched its cholesterol medication, Repatha, directly to consumers in the U.S. at a reduced cash price. This move comes as part of a broader response fr...
10-06 23:12
派息除权日
|
每股总股息
| 派息日期 |
2025-07-25
|
0.43
|
2025-09-02
|
2025-05-09
|
0.43
|
2025-06-13
|
2025-01-24
|
0.43
|
2025-03-07
|
2024-11-08
|
0.42
|
2024-12-02
|
2024-07-26
|
0.42
|
2024-09-03
|
2024-05-09
|
0.42
|
2024-06-14
|
2024-01-25
|
0.42
|
2024-03-01
|
2023-11-09
|
0.41
|
2023-12-04
|
2023-07-27
|
0.41
|
2023-09-05
|
2023-05-11
|
0.41
|
2023-06-09
|
2023-01-26
|
0.41
|
2023-03-03
|
2022-11-03
|
0.40
|
2022-12-05
|
2022-07-28
|
0.40
|
2022-09-06
|
2022-05-12
|
0.40
|
2022-06-10
|
2022-01-27
|
0.40
|
2022-03-04
|
2021-11-04
|
0.39
|
2021-12-06
|
2021-07-29
|
0.39
|
2021-09-07
|
2021-05-06
|
0.39
|
2021-06-04
|
2021-01-28
|
0.39
|
2021-03-05
|
2020-11-05
|
0.38
|
2020-12-01
|
2020-07-30
|
0.38
|
2020-09-01
|
2020-05-07
|
0.38
|
2020-06-05
|
2020-01-30
|
0.38
|
2020-03-06
|
2019-11-07
|
0.36
|
2019-12-02
|
2019-08-01
|
0.36
|
2019-09-03
|
2019-05-09
|
0.36
|
2019-06-07
|
2019-01-31
|
0.36
|
2019-03-01
|
2018-11-08
|
0.34
|
2018-12-03
|
2018-08-02
|
0.34
|
2018-09-04
|
2018-05-10
|
0.34
|
2018-06-01
|
2018-02-01
|
0.34
|
2018-03-01
|
2017-11-09
|
0.32
|
2017-12-01
|
2017-08-02
|
0.32
|
2017-09-01
|
2017-05-10
|
0.32
|
2017-06-01
|
2017-02-01
|
0.32
|
2017-03-01
|
2016-11-08
|
0.30
|
2016-12-01
|
2016-08-03
|
0.30
|
2016-09-01
|
2016-05-11
|
0.30
|
2016-06-01
|
2016-02-03
|
0.30
|
2016-03-02
|
2015-11-04
|
0.28
|
2015-12-01
|
2015-08-05
|
0.28
|
2015-09-02
|
2015-05-06
|
0.28
|
2015-06-02
|
2015-02-04
|
0.28
|
2015-03-03
|
2014-11-05
|
0.26
|
2014-12-02
|
2014-07-30
|
0.26
|
2014-09-03
|
2014-05-07
|
0.26
|
2014-06-03
|
2014-02-05
|
0.26
|
2014-03-04
|
2013-11-06
|
0.24
|
2013-12-03
|
2013-07-31
|
0.24
|
2013-09-04
|
2013-05-08
|
0.24
|
2013-06-04
|
2013-01-30
|
0.24
|
2013-03-05
|
2012-11-07
|
0.22
|
2012-12-04
|
2012-08-01
|
0.22
|
2012-09-05
|
2012-05-09
|
0.22
|
2012-06-05
|
2012-02-01
|
0.22
|
2012-03-06
|
2011-11-08
|
0.20
|
2011-12-06
|
2011-08-03
|
0.20
|
2011-09-06
|
2011-05-11
|
0.20
|
2011-06-07
|
2011-02-02
|
0.20
|
2011-03-01
|
2010-11-04
|
0.18
|
2010-12-01
|
2010-08-04
|
0.18
|
2010-09-01
|
2010-05-05
|
0.18
|
2010-06-01
|
2010-02-03
|
0.18
|
2010-03-02
|
2009-11-04
|
0.16
|
2009-12-01
|
2009-08-05
|
0.16
|
2009-09-02
|
2009-05-06
|
0.16
|
2009-06-02
|
2009-02-04
|
0.32
|
2009-03-03
|
2008-11-05
|
0.32
|
2008-12-02
|
2008-08-06
|
0.32
|
2008-09-03
|
2008-05-07
|
0.32
|
2008-06-03
|
2008-02-06
|
0.32
|
2008-03-04
|
2007-11-07
|
0.29
|
2007-12-04
|
2007-08-08
|
0.29
|
2007-09-05
|
2007-05-09
|
0.29
|
2007-06-05
|
2007-02-07
|
0.29
|
2007-03-06
|
2006-11-08
|
0.24
|
2006-12-05
|
2006-08-09
|
0.24
|
2006-09-05
|
2006-05-10
|
0.24
|
2006-06-06
|
2006-02-08
|
0.24
|
2006-03-07
|
2005-11-08
|
0.19
|
2005-12-06
|
2005-08-10
|
0.19
|
2005-09-06
|
2005-05-11
|
0.19
|
2005-06-07
|
2005-02-09
|
0.19
|
2005-03-08
|
2004-11-09
|
0.17
|
2004-12-03
|
2004-08-11
|
0.17
|
2004-09-03
|
2004-05-12
|
0.17
|
2004-06-04
|
2004-02-11
|
0.17
|
2004-03-05
|
2003-11-12
|
0.15
|
2003-12-04
|
2003-08-13
|
0.15
|
2003-09-04
|
2003-05-14
|
0.15
|
2003-06-05
|
2003-01-15
|
0.15
|
2003-02-14
|
2002-11-13
|
0.13
|
2002-12-05
|
2002-08-14
|
0.13
|
2002-09-05
|
2002-05-15
|
0.13
|
2002-06-06
|
2002-02-13
|
0.13
|
2002-03-07
|
2001-11-14
|
0.11
|
2001-12-06
|
2001-08-15
|
0.11
|
2001-09-06
|
2001-05-16
|
0.11
|
2001-06-07
|
2001-02-14
|
0.11
|
2001-03-08
|
2000-11-15
|
0.09
|
2000-12-07
|
2000-08-16
|
0.09
|
2000-09-07
|
2000-05-09
|
0.09
|
2000-06-08
|
2000-02-16
|
0.09
|
2000-03-09
|
1999-11-09
|
0.08
|
1999-12-09
|
1999-08-04
|
0.08
|
1999-09-09
|
1999-05-05
|
0.22
|
1999-06-10
|
1999-02-10
|
0.22
|
1999-03-11
|
1998-11-04
|
0.19
|
1998-12-10
|
1998-08-05
|
0.19
|
1998-09-10
|
1998-05-06
|
0.19
|
1998-06-11
|
1998-02-04
|
0.19
|
1998-03-12
|
1997-11-05
|
0.17
|
1997-12-11
|
1997-07-30
|
0.17
|
1997-09-11
|
1997-05-07
|
0.34
|
1997-06-12
|
1997-02-05
|
0.34
|
1997-03-13
|
1996-11-06
|
0.30
|
1996-12-12
|
1996-07-31
|
0.30
|
1996-09-12
|
1996-05-08
|
0.30
|
1996-06-13
|
1996-02-07
|
0.30
|
1996-03-14
|
1995-11-08
|
0.26
|
1995-12-21
|
1995-08-02
|
0.26
|
1995-09-21
|
1995-05-08
|
0.52
|
1995-06-15
|
1995-02-06
|
0.52
|
1995-03-16
|
1994-11-04
|
0.47
|
1994-12-15
|
1994-08-01
|
0.47
|
1994-09-15
|
1994-05-09
|
0.47
|
1994-06-16
|
1994-02-07
|
0.47
|
1994-03-17
|
1993-11-05
|
0.42
|
1993-12-16
|
1993-08-02
|
0.42
|
1993-09-16
|
1993-05-10
|
0.42
|
1993-06-17
|
1993-02-08
|
0.42
|
1993-03-18
|
1992-11-16
|
0.37
|
1992-12-17
|
1992-08-03
|
0.37
|
1992-09-17
|
1992-05-11
|
0.37
|
1992-06-18
|
1992-02-03
|
0.37
|
1992-03-19
|
1991-11-08
|
0.33
|
1991-12-19
|
1991-08-01
|
0.33
|
1991-09-19
|
1991-05-13
|
0.33
|
1991-06-20
|
1991-02-22
|
0.66
|
1991-03-21
|
1990-11-09
|
0.60
|
1990-12-20
|
1990-08-06
|
0.60
|
1990-09-20
|
1990-05-14
|
0.60
|
1990-06-21
|
1990-02-05
|
0.60
|
1990-03-22
|
1989-11-13
|
0.55
|
1989-12-21
|
1989-07-24
|
0.55
|
1989-09-21
|
1989-05-15
|
0.55
|
1989-06-21
|
1989-01-23
|
0.55
|
1989-03-22
|
1988-11-15
|
0.50
|
1988-12-20
|
1988-07-25
|
0.50
|
1988-09-20
|
1988-05-16
|
0.50
|
1988-06-20
|
1988-02-12
|
0.50
|
1988-03-21
|
1987-11-16
|
0.45
|
1987-12-21
|
1987-07-27
|
0.45
|
1987-09-21
|
1987-05-14
|
0.45
|
1987-06-19
|
1987-01-26
|
0.45
|
1987-03-20
|
1986-11-17
|
0.41
|
1986-12-19
|
1986-07-28
|
0.41
|
1986-09-19
|
1986-05-14
|
0.41
|
1986-06-20
|
1986-01-27
|
0.41
|
1986-03-21
|
1985-11-15
|
0.37
|
1985-12-20
|
1985-07-26
|
0.37
|
1985-09-20
|
1985-05-20
|
0.37
|
1985-06-21
|
1985-01-28
|
0.37
|
1985-03-21
|
1984-11-13
|
0.33
|
1984-12-20
|
1984-07-26
|
0.33
|
1984-09-20
|
1984-05-14
|
0.33
|
1984-06-21
|
1984-01-26
|
0.33
|
1984-03-21
|
1983-11-14
|
0.29
|
1983-12-21
|
1983-07-26
|
0.29
|
1983-09-21
|
1983-05-13
|
0.58
|
1983-06-21
|
1983-01-26
|
0.58
|
1983-03-21
|
1982-11-15
|
0.46
|
1982-12-21
|
1982-07-27
|
0.46
|
1982-09-21
|
1982-05-13
|
0.46
|
1982-06-21
|
1982-01-26
|
0.46
|
1982-03-19
|
1981-11-13
|
0.40
|
1981-12-21
|
1981-08-13
|
0.40
|
1981-09-21
|
1981-05-13
|
0.40
|
1981-06-19
|
1981-02-11
|
0.40
|
1981-03-20
|
1980-11-28
|
0.36
|
1980-12-22
|
1980-09-02
|
0.36
|
1980-09-29
|
1980-05-29
|
0.36
|
1980-06-27
|
1980-03-03
|
0.36
|
1980-03-30
|
1979-11-22
|
0.33
|
1979-12-18
|
1979-08-27
|
0.33
|
1979-09-20
|
1979-05-23
|
0.33
|
1979-06-21
|
1979-03-05
|
0.33
|
1979-03-29
|
1978-11-21
|
0.30
|
1978-12-17
|
1978-08-28
|
0.30
|
1978-09-21
|
1978-05-25
|
0.30
|
1978-06-22
|
1978-02-27
|
0.27
|
1978-03-23
|
1977-11-24
|
0.27
|
1977-12-18
|
1977-09-01
|
0.24
|
1977-09-22
|
1977-05-30
|
0.24
|
1977-06-23
|
1977-02-28
|
0.24
|
1977-03-24
|
